drugset

drugset / Trial / NCT01635062

The VALIDATE-D Study

NCT01635062 ↗

Completed 41 enrolled Brigham and Women's Hospital

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate whether vitamin D receptor agonist therapy lowers renin-angiotensin system activity.

Timeline

Start: 2012-09
Primary completion: 2015-12
Completion: 2015-12

Publications

Brown JM, Secinaro K, Williams JS, Vaidya A. Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study. BMC Endocr Disord. 2013 Aug 23;13:33. doi: 10.1186/1472-6823-13-33.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Calcitriol	Small molecule	0.75 ug	—

Indications